Personal profile
Research interests
Dr. Paul Kocis, a clinical pharmacist, developed and continues to maintain a computerized monitoring process to systematically evaluate and report on warfarin point-of-care INR accuracy discrepancies within Penn State Health Milton S. Hershey Medical Center. His IRB-approved research has resulted in the publication of several abstracts and scientific posters for various scientific congresses on the topic of warfarin point-of-care testing. He is also a principal investigator for a number of IRB-approved research projects designed to better understand the patient characteristics, bleeding and thrombosis events associated with direct oral anticoagulants and warfarin.
In addition, Dr. Kocis has an academic interest in the clinical effects of drug-drug interaction.
Clinical interests
Dr. Paul Kocis is a clinical pharmacist in the anticoagulation clinic of the Department of Pharmacy's disease state management team at Penn State Health Milton S. Hershey Medical Center. There, he manages the warfarin regimens of the most medically complex patients, including those with total artificial heart and left ventricular assist devices, and from the hematology, oncology, transplant, cardiology and neurology patient populations.
External positions
Voting and Writing Group Member, Clinical and Laboratory Standards Institute
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Benchmark Evaluation of a Cannabinoid Drug Interaction Chatbot
Liu, Y., Kocis, P. T. & Rabadi, D., Feb 6 2026, Zenodo.Research output: Other contribution
-
Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients
Yao, S.-Y., Kocis, P. T., Murphy, T. & Hwang, W., 2025, In: Pharmacoepidemiology. 4, 1, p. 6Research output: Contribution to journal › Article › peer-review
-
Anticoagulant, Antiplatelet, & Fibrinolytic Medications
Kocis, P. T., Apr 24 2024, Brody's Human Pharmacology. 7th ed. ElsevierResearch output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review
-
Anticoagulant, Antiplatelet, and Fibrinolytic Medications
Kocis, P. T., Herrmann, F., Karpa, K. & Vrana, K. E., Jan 1 2024, Brody's Human Pharmacology. Elsevier, p. 406-415 10 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
1 Link opens in a new tab Scopus citations -
Cannabinoid Awareness, Reporting Use to Health Care Providers, and Perceptions Regarding Safety - Pennsylvania, March 2023-April 2023
Kocis, P. T., Mallinson, D. J. & Servinsky, T. J., Jul 17 2024, In: Medical Cannabis and Cannabinoids. 7, 1, p. 119-124 6 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations
Activities
- 1 Invited talk
-
Public Workshop on Warfarin Point-of-Care Testing
Kocis, P. (Speaker)
Mar 2016Activity: Talk types › Invited talk